» Articles » PMID: 27022628

Normal Performance of Fmr1 Mice on a Touchscreen Delayed Nonmatching to Position Working Memory Task

Overview
Journal eNeuro
Specialty Neurology
Date 2016 Mar 30
PMID 27022628
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Fragile X syndrome is a neurodevelopmental disorder characterized by mild-to-severe cognitive deficits. The complete absence of Fmr1 and its protein product in the mouse model of fragile X (Fmr1 KO) provides construct validity. A major conundrum in the field is the remarkably normal performance of Fmr1 mice on cognitive tests in most reports. One explanation may be insufficiently challenging cognitive testing procedures. Here we developed a delayed nonmatching to position touchscreen task to test the hypothesis that paradigms placing demands on working memory would reveal robust and replicable cognitive deficits in the Fmr1 KO mouse. We first tested Fmr1 KO mice (Fmr1) and their wild-type (WT) littermates in a simple visual discrimination task, followed by assessment of reversal learning. We then tested Fmr1 and WT mice in a new touchscreen nonmatch to position task and subsequently challenged their working memory abilities by adding delays, representing a higher cognitive load. The performance by Fmr1 KO mice was equal to WTs on both touchscreen tasks. Last, we replicated previous reports of normal performance by Fmr1 mice on Morris water maze spatial navigation and reversal. These results indicate that, while the Fmr1 mouse model effectively recapitulates many molecular and cellular aspects of fragile X syndrome, the cognitive profile of Fmr1 mice generally does not recapitulate the primary cognitive deficits in the human syndrome, even when diverse and challenging tasks are imposed.

Citing Articles

Poly (I:C)-induced maternal immune activation generates impairment of reversal learning performance in offspring.

Munarriz-Cuezva E, Meana J J Neurochem. 2024; 169(1):e16212.

PMID: 39183542 PMC: 11657921. DOI: 10.1111/jnc.16212.


mGluR7 allosteric modulator AMN082 corrects protein synthesis and pathological phenotypes in FXS.

Kumar V, Lee K, Acharya A, Babik M, Christian-Hinman C, Rhodes J EMBO Mol Med. 2024; 16(3):506-522.

PMID: 38374465 PMC: 10940663. DOI: 10.1038/s44321-024-00038-w.


Parallel learning and cognitive flexibility impairments between knockout mice and individuals with fragile X syndrome.

Schmitt L, Arzuaga A, Dapore A, Duncan J, Patel M, Larson J Front Behav Neurosci. 2023; 16:1074682.

PMID: 36688132 PMC: 9849779. DOI: 10.3389/fnbeh.2022.1074682.


Visiomode: An open-source platform for building rodent touchscreen-based behavioral assays.

Eleftheriou C, Clarke T, Poon V, Zechner M, Duguid I J Neurosci Methods. 2023; 386:109779.

PMID: 36621552 PMC: 10375831. DOI: 10.1016/j.jneumeth.2022.109779.


New Animal Models for Understanding FMRP Functions and FXS Pathology.

Curnow E, Wang Y Cells. 2022; 11(10).

PMID: 35626665 PMC: 9140010. DOI: 10.3390/cells11101628.


References
1.
DHooge R, Nagels G, Franck F, Bakker C, Reyniers E, Storm K . Mildly impaired water maze performance in male Fmr1 knockout mice. Neuroscience. 1997; 76(2):367-76. DOI: 10.1016/s0306-4522(96)00224-2. View

2.
Logue S, Paylor R, Wehner J . Hippocampal lesions cause learning deficits in inbred mice in the Morris water maze and conditioned-fear task. Behav Neurosci. 1997; 111(1):104-13. DOI: 10.1037//0735-7044.111.1.104. View

3.
Michalon A, Bruns A, Risterucci C, Honer M, Ballard T, Ozmen L . Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice. Biol Psychiatry. 2013; 75(3):189-97. DOI: 10.1016/j.biopsych.2013.05.038. View

4.
van Nieuwpoort I, Deijen J, Curfs L, Drent M . The relationship between IGF-I concentration, cognitive function and quality of life in adults with Prader-Willi syndrome. Horm Behav. 2011; 59(4):444-50. DOI: 10.1016/j.yhbeh.2011.01.001. View

5.
Romberg C, Mattson M, Mughal M, Bussey T, Saksida L . Impaired attention in the 3xTgAD mouse model of Alzheimer's disease: rescue by donepezil (Aricept). J Neurosci. 2011; 31(9):3500-7. PMC: 3066152. DOI: 10.1523/JNEUROSCI.5242-10.2011. View